Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

Juan Li, Auke P Verhaar, Qiuwei Pan, Robert Jacobus de Knegt, Maikel P Peppelenbosch Erasmus MC Cancer Institute, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands Background and aim: Caspase-cleaved cytokeratin 18 (CK18-Asp396) is a pot...

Full description

Bibliographic Details
Main Authors:	Li J, Verhaar AP, Pan Q, de Knegt RJ, Peppelenbosch MP
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-08-01
Series:	Clinical and Experimental Gastroenterology
Subjects:	CHB CK-18 apoptosis steatosis inflammation
Online Access:	https://www.dovepress.com/serum-levels-of-caspase-cleaved-cytokeratin-18-ck18-asp396-predict-sev-peer-reviewed-article-CEG

Similar Items

Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity
by: Joanna Goralska, et al.
Published: (2023-04-01)

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
by: Anne Menz, et al.
Published: (2021-02-01)

Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population
by: Atif Ali Hashmi, et al.
Published: (2018-06-01)

The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage
by: Akiko Eguchi, et al.
Published: (2022-08-01)

Immunohistochemical Study of CK18 Expression In Head and Neck Squamous Cell Carcinoma
by: Mustafa Mohammed Abdulhussain
Published: (2019-05-01)

Immunohistochemical Study of CK18 Expression In Head and Neck Squamous Cell Carcinoma
by: Mustafa Mohammed Abdulhussain
Published: (2019-05-01)

High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality
by: Leonardo Lorente, et al.
Published: (2018-03-01)

Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage
by: Leonardo Lorente, et al.
Published: (2018-04-01)

THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER
by: Sevki PEDUK, et al.
Published: (2018-12-01)

Immunohistochemical analysis of CK 18 in dental follicles of impacted third molars: A pilot study
by: Anand S Tegginamani, et al.
Published: (2013-01-01)

Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: A prospective study
by: Polychronidis Alexandros, et al.
Published: (2008-05-01)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
by: Jaudah Al-Maghrabi, et al.
Published: (2018-01-01)

Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus
by: Fang Li, et al.
Published: (2021-10-01)

High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients
by: Leonardo Lorente, et al.
Published: (2019-10-01)

Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery
by: Felix Hempel, et al.
Published: (2021-03-01)

Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study.
by: Leonardo Lorente, et al.
Published: (2014-01-01)

Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emi
by: Oğuz Abdullah Uyaroğlu
Published: (2020-06-01)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
by: Andrea Baier, et al.
Published: (2022-10-01)

CK2—An Emerging Target for Neurological and Psychiatric Disorders
by: Julia Castello, et al.
Published: (2017-01-01)

Evaluation of vegf, cytokeratin-19 and caspase 3 immunolocalization in the lung tissue of rat with experimentally İnduced diabetes
by: Zeynep Deniz ŞAHİN İNAN, et al.
Published: (2019-01-01)

Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer
by: Alice Court, et al.
Published: (2022-06-01)

Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study
by: Sitong Yi, et al.
Published: (2024-01-01)

Role Of TTF-1, CK20, And CK7 Immunohistochemistry for Diagnosis of Primary and Secondary Lung Adenocarcinoma
by: Yue-Chiu Su, et al.
Published: (2006-01-01)

Clinicopathological Evaluation of Gall-Bladder Lesions in Cholecystectomy Specimens with Special Emphasis to Incidentally Detected Cases of Gall-Bladder Carcinoma Along with Immunohistochemical Study of Cytokeratin 7 and Cytokeratin 20
by: Kakoli Bora, et al.
Published: (2023-08-01)

Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
by: Yan Li, et al.
Published: (2023-11-01)

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
by: Bayrak Reyhan, et al.
Published: (2012-01-01)

Expression of (TTF-1), CK-7 and CK-20 Immunohistochemical Marker in Neoplastic and Non-neoplastic Endometrium.
by: Sazan A. AL-Atrooshi, et al.
Published: (2015-01-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

ESTUDO DO COMPORTAMENTO DA CREATINO QUINASE (CK) E CREATINO QUINASE-MB (CK-MB) SÉRICA DE CÃES SUBMETIDOS À OXIGENAÇÃO POR MEMBRANA EXTRACORPÓREA (ECMO) DURANTE UM PERÍODO DE TRÊS HORAS
by: Felipp Silveira Ferreira, et al.
Published: (2010-10-01)

Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
by: Leonardo Lorente, et al.
Published: (2015-01-01)

Predictive value of CK5 and CK20 for prognosis in upper urinary tract urothelial carcinoma
by: LIU Chuan, et al.
Published: (2022-05-01)

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
by: Qi Zheng, et al.
Published: (2021-12-01)

Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
by: Qi Zheng, et al.
Published: (2022-01-01)

Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
by: Cha Seung-Ick, et al.
Published: (2012-11-01)

Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study
by: Danial Fazilat-Panah, et al.
Published: (2020-04-01)

Zebrafish as model system for the biological characterization of CK1 inhibitors
by: Laura Meier, et al.
Published: (2023-09-01)

Cytokeratin 20-positive hepatocellular carcinoma
by: G. Faa, et al.
Published: (2009-12-01)

Importance of cytokeratin-20 expression in papillary urothelial neoplasia
by: İbrahim Karabulut, et al.
Published: (2020-12-01)

Gender differences in serum CK-MB mass levels in healthy Braziliansubjects
by: C.M.C. Strunz, et al.
Published: (2011-03-01)

Gender differences in serum CK-MB mass levels in healthy Braziliansubjects
by: C.M.C. Strunz, et al.
Published: (2011-03-01)